Please try another search
Alcidion Group Limited is an Australia-based healthcare technology company. Its principal activities include the development and licensing of its own healthcare software products (Miya, Patientrack, Smartpage and ExtraMed); reselling of selected healthcare software products from its strategic partners; and the delivery of product implementation, product support and maintenance, systems integration; data analysis services to healthcare customers in Australia, New Zealand and the United Kingdom. Its healthcare software products include Miya, Patientrack, Smartpage and ExtraMed. Miya Precision is a clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. Smartpage is a smartphone and Web-based system for hospital communication and task management provides solution to both clinical and non-clinical users. Patientrack is a solution that supports the capture of that data at the bedside. Its clinical solutions use digital technology.
Name | Age | Since | Title |
---|---|---|---|
Malcolm Pradhan | - | 2016 | Chief Medical Officer, Product Manager & Executive Director |
Rebecca Wilson | - | 2017 | Independent Chair |
Kate Quirke | - | 2018 | MD, CEO & Executive Director |
Nicholas Paul Dignam | - | 2016 | Independent Non Executive Director |
Daniel Sharp | - | 2021 | Independent Non-Executive Director |
Victoria Sophia Mary Weekes | - | 2021 | Independent Non-Executive Director |
Simon Chamberlain | - | 2019 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review